Home > > > Report Detail

Epigenetics Market by Product & Service (Enzymes (DNA-modifying Enzymes), Kits & Reagents (Antibodies), Instrument, Software), Method (DNA Methylation), Technique (NGS, PCR, Mass Spectrometry), Application (Oncology, Immunology) - Global Forecast to 2028

Publisher Name :
Date: 13-Dec-2023
No. of pages: 366
Inquire Before Buying

“The epigenetics market is projected to grow at a CAGR of 18.3% during the forecast period of 2023-2028.”

The global epigenetics market size is projected to reach USD 4.3 billion by 2028 from USD 1.8 billion in 2023, at a CAGR of 18.3% during the forecast period. Factors such as increased investments in research and development, coupled with a reduction in sequencing costs and time, support from government initiatives and funding for epigenetics research, advancements in technology for epigenetic research, and a growing interest in epigenetic-based therapeutics.

“The kits & reagents segment segment held the dominant share in the epigenetics market”

Based on product & service, the global epigenetics market is segmented into kits & reagents, enzymes, instruments and accessories, software, and service. The kits & reagents segment  is anticipated to grow at significant CAGR. The rapid expansion of epigenetics studies, combined with the introduction of cost-effective and user-friendly kits by market participants are likely to have positive impact on the growth of the market.

“DNA methylation segment accounted for the largest share of the method segment in 2022.”

Based on method, the epigenetics market is segmented into, DNA methylation, histone modifications, and other methods. In 2022, the DNA methylation segment accounted for the largest share of the epigenetics market. The segment held the dominant share in the market owing to the effectiveness of employing DNA methylation techniques for cancer research.

“Asia Pacific region is likely to grow at a faster pace in the epigenetics market.”

The epigenetics market region is segmented into North America, Europe, Asia Pacific, Latin America, Middle East and the Africa. Asia Pacific region is anticipated to grow at a significant CAGR during the forecast period. The growth of the region is majorly driven by enhancements in healthcare infrastructure within developing APAC economies, coupled with strategic partnerships, collaborations, agreements, and expansions pursued by local industry players.

The primary interviews conducted for this report can be categorized as follows:


  • By Respondent: Supply Side- 60%, and Demand Side - 40%

  • By Designation (Supply Side): Managers - 45%, CXOs & Directors - 30%, Executives- 25%

  • By Region: North America: 40%, Europe: 27%, Asia Pacific: 20%, Latin America: 10%, and the Middle East & Africa: 3%


List of Companies Profiled in the Report:


  • Thermo Fisher Scientific Inc. (US)

  • Merck KGaA (Germany)

  • Illumina, Inc. (US)

  • PacBio (US)

  • Abcam plc (UK)

  • Active Motif, Inc. (US)

  • Bio-Rad Laboratories Inc. (US)

  • Promega Corporation (US)

  • Revvity (US)

  • Qiagen (Germany)

  • New England Biolabs (US)

  • Zymo Research Corporation (US)

  • Diagenode SA(US)

  • F. Hoffmann-La Roche Ltd (Switzerland)

  • EpiGentek Group Inc. (US)

  • EpiCypher (US)

  • Fios Genomics (UK)

  • GenomeScan (Netherlands)

  • Creative Biogene (US)

  • BPS Bioscienc Inc (US)

  • Abnova Corporation (Taiwan)

  • Creative Diagnostics (US)

  • Biomodal (UK)

  • Integrated DNA Technologies Inc. (US)

  • Novogene Co Ltd (China)


Research Coverage:

This report provides a detailed picture of the epigenetics market. It aims at estimating the size and future growth potential of the market across different segments such as the technology, type, disease indication, route of administration, end-user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall epigenetics market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:


  • Analysis of key drivers (growing investment in research & development, declining sequencing cost & time, favorable government initiatives and funding for epigenetics research, technological advancements in epigenetic research and rising demand for epigenetic-based therapeutics), restraints (Limited application of epigenomic data in toxicology, data privacy concern and security issues associated with management of large scale- epigenetic data ), opportunities (Expanding application of epigenetics and integration of artificial intelligence and machine learning algorithm) and challenges (Concerns Regarding the Quality of Antibodies, Challenges associated epigenetics editing, off target effect) are influencing the growth of epigenetics market.

  • Product Development/Innovation: Detailed insights on newly launched products of the epigenetics market.

  • Market Development: Comprehensive information about lucrative markets – the report analyses the epigenetics market across varied regions.

  • Market Diversification: Exhaustive information about new services, untapped geographies, recent developments, and investments in the epigenetics market.  

  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Illumina, Inc. (US), PacBio (US), Abcam plc (UK), Active Motif, Inc. (US), Bio-Rad Laboratories Inc. (US), Promega Corporation (US), Revvity (US) and Qiagen (Germany).

Epigenetics Market by Product & Service (Enzymes (DNA-modifying Enzymes), Kits & Reagents (Antibodies), Instrument, Software), Method (DNA Methylation), Technique (NGS, PCR, Mass Spectrometry), Application (Oncology, Immunology) - Global Forecast to 2028

Table Of Contents

1 Introduction 44
1.1 Study Objectives 44
1.2 Market Definition 44
1.2.1 Inclusions & Exclusions 45
1.3 Market Scope 45
1.3.1 Markets Covered 45
1.3.2 Years Considered 46
1.3.3 Currency Considered 46
1.4 Research Limitations 46
1.5 Stakeholders 47
1.6 Summary Of Changes 47
1.7 Recession Impact 48

2 Research Methodology 49
2.1 Research Data 49
Figure 1 Research Design 49
2.1.1 Secondary Data 50
2.1.2 Primary Data 51
Figure 2 Breakdown Of Primaries 51
2.2 Market Size Estimation 52
Figure 3 Market Size Estimation: Epigenetics Market (2022) 52
Figure 4 Approach 1: Revenue Share Analysis 53
Figure 5 Revenue Share Analysis Of Thermo Fisher Scientific Inc.: Epigenetics Market (2022) 53
2.2.1 Primary Insights 54
Figure 6 Market Validation From Primary Experts 54
2.2.2 Segmental Assessment: Epigenetics Market 55
Figure 7 Market Size Estimation: Top-Down Approach 55
2.3 Growth Rate Assumptions 56
Figure 8 Cagr Projection: Epigenetics Market 56
Figure 9 Growth Analysis Of Drivers, Restraints, Challenges, And Opportunities 57
2.4 Market Breakdown & Data Triangulation 58
Figure 10 Data Triangulation Methodology 58
2.5 Study Assumptions 59
2.6 Risk Analysis 59
2.7 Recession Impact: Epigenetics Market 59
Table 1 Global Inflation Rate Projection, 2021–2028 (% Growth) 60
Table 2 Us Health Expenditure, 2019–2022 (Usd Million) 60
Table 3 Us Health Expenditure, 2023–2027 (Usd Million) 60

3 Executive Summary 61
Figure 11 Epigenetics Market, By Product & Service, 2023 Vs. 2028 (Usd Million) 61
Figure 12 Epigenetics Market, By Method, 2023 Vs. 2028 (Usd Million) 62
Figure 13 Epigenetics Market, By Technique, 2023 Vs. 2028 (Usd Million) 62
Figure 14 Epigenetics Market, By Application, 2023 Vs. 2028 (Usd Million) 63
Figure 15 Epigenetics Market, By End User, 2023 Vs. 2028 (Usd Million) 63
Figure 16 Geographical Snapshot Of Epigenetics Market 64

4 Premium Insights 65
4.1 Epigenetics Market Overview 65
Figure 17 Declining Sequencing Costs & Time To Drive Market Growth During Forecast Period 65
4.2 North America: Epigenetics Market, By Product & Service And Country (2022) 66
Figure 18 Kits & Reagents Segment Accounted For Largest Share Of North American Epigenetics Market In 2022 66
4.3 Epigenetics Market Share, By Product & Service, 2023 Vs. 2028 67
Figure 19 Kits & Reagents Segment To Continue To Dominate Market In 2028 67
4.4 Epigenetics Market: Geographic Growth Opportunities 67
Figure 20 Asia Pacific Countries To Register Highest Growth Rates From 2023 To 2028 67

5 Market Overview 68
5.1 Introduction 68
5.2 Market Dynamics 68
Figure 21 Epigenetics Market: Drivers, Restraints, Opportunities, And Challenges 68
Table 4 Impact Analysis: Epigenetics Market 69
5.2.1 Drivers 69
5.2.1.1 Growing Investments In Research & Development 69
5.2.1.2 Declining Sequencing Costs & Time 70
Figure 22 Cost Of Human Whole-Genome Sequencing, 2001–2020 71
5.2.1.3 Favorable Government Initiatives And Funding For Epigenetics Research 72
5.2.1.4 Technological Advancements In Epigenetics Research 72
5.2.1.5 Rising Demand For Epigenetic-Based Therapeutics 73
Figure 23 Number Of Cancer Cases In Us, 2017–2022 74
5.2.2 Restraints 74
5.2.2.1 Limited Applications Of Epigenomic Data In Toxicology 74
5.2.2.2 Data Privacy Concerns And Security Issues 75
5.2.3 Opportunities 75
5.2.3.1 Expanding Applications Of Epigenetics 75
5.2.3.2 Integration Of Artificial Intelligence And Machine Learning Algorithms 76
5.2.4 Challenges 76
5.2.4.1 Concerns Regarding Quality Of Antibodies 76
5.2.4.2 Challenges Associated With Epigenetic Editing 77
5.3 Trends/Disruptions Impacting Customers’ Businesses 77
Figure 24 Revenue Shift And New Revenue Pockets For Epigenetics Providers 77
5.4 Pricing Analysis 78
5.4.1 Average Selling Price Of Products, By Key Player 78
Table 5 Average Selling Price Of Products, By Key Player 78
5.4.2 Average Selling Price Trend 79
5.5 Technology Analysis 79
5.6 Value Chain Analysis 80
Figure 25 Value Chain Analysis: Raw Material And Manufacturing Phases Contribute Maximum Value 80
5.7 Ecosystem Map 81
Figure 26 Ecosystem Map 81
Table 6 Role In Ecosystem: Epigenetics Market 81
5.8 Regulatory Analysis 83
Table 7 Key Regulatory Agencies 83
5.8.1 Regulatory Bodies, Government Agencies, And Other Organizations 85
Table 8 North America: Regulatory Bodies, Government Agencies, And Other Organizations 85
Table 9 Europe: Regulatory Bodies, Government Agencies, And Other Organizations 86
Table 10 Asia Pacific: Regulatory Bodies, Government Agencies, And Other Organizations 86
Table 11 Latin America: Regulatory Bodies, Government Agencies, And Other Organizations 87
Table 12 Middle East: Regulatory Bodies, Government Agencies, And Other Organizations 87
Table 13 Africa: Regulatory Bodies, Government Agencies, And Other Organizations 88
5.9 Porter’s Five Forces Analysis 88
Table 14 Porter’s Five Forces Analysis: Epigenetics Market 88
5.9.1 Threat Of New Entrants 88
5.9.2 Threat Of Substitutes 89
5.9.3 Bargaining Power Of Suppliers 89
5.9.4 Bargaining Power Of Buyers 89
5.9.5 Intensity Of Competitive Rivalry 89
5.10 Patent Analysis 90
Figure 27 Patent Applications For Epigenetics, November 2013–November 2023 90
Table 15 Indicative List Of Patents: Epigenetics Market 90
5.11 Key Conferences & Events 91
Table 16 Detailed List Of Key Conferences & Events, 2023–2024 91
5.12 Key Stakeholders & Buying Criteria 92
5.12.1 Key Stakeholders In Buying Process 92
Figure 28 Influence Of Stakeholders On Buying Process Of Epigenetics 92
5.12.2 Buying Criteria For Epigenetics 93
Figure 29 Key Buying Criteria For End Users 93

6 Epigenetics Market, By Product & Service 94
6.1 Introduction 95
Table 17 Epigenetics Market, By Product & Service, 2021–2028 (Usd Million) 95
6.2 Kits & Reagents 95
Table 18 Epigenetics Market For Kits & Reagents, By Type, 2021–2028 (Usd Million) 96
Table 19 Epigenetics Market For Kits & Reagents, By Region, 2021–2028 (Usd Million) 96
Table 20 North America: Epigenetics Market For Kits & Reagents, By Country, 2021–2028 (Usd Million) 97
Table 21 Europe: Epigenetics Market For Kits & Reagents, By Country, 2021–2028 (Usd Million) 97
Table 22 Asia Pacific: Epigenetics Market For Kits & Reagents, By Country, 2021–2028 (Usd Million) 98
Table 23 Latin America: Epigenetics Market For Kits & Reagents, By Country, 2021–2028 (Usd Million) 98
6.2.1 Antibodies 98
6.2.1.1 Growing Demand For Recombinant Antibodies For Detection Of Epigenetic Targets To Propel Growth 98
Table 24 Epigenetics Market For Antibodies, By Region, 2021–2028 (Usd Million) 99
Table 25 North America: Epigenetics Market For Antibodies, By Country, 2021–2028 (Usd Million) 100
Table 26 Europe: Epigenetics Market For Antibodies, By Country, 2021–2028 (Usd Million) 100
Table 27 Asia Pacific: Epigenetics Market For Antibodies, By Country, 2021–2028 (Usd Million) 101
Table 28 Latin America: Epigenetics Market For Antibodies, By Country, 2021–2028 (Usd Million) 101
6.2.2 Chip-Sequencing Kits & Reagents 101
6.2.2.1 Versatile Applications Of Chromatin Immunoprecipitation (Chip) Pertaining To Epigenetic Regulatory Systems To Boost Demand 101
Table 29 Epigenetics Market For Chip-Sequencing Kits & Reagents, By Region, 2021–2028 (Usd Million) 102
Table 30 North America: Epigenetics Market For Chip-Sequencing Kits & Reagents, By Country, 2021–2028 (Usd Million) 102
Table 31 Europe: Epigenetics Market For Chip-Sequencing Kits & Reagents, By Country, 2021–2028 (Usd Million) 103
Table 32 Asia Pacific: Epigenetics Market For Chip-Sequencing Kits & Reagents, By Country, 2021–2028 (Usd Million) 103
Table 33 Latin America: Epigenetics Market For Chip-Sequencing Kits & Reagents, By Country, 2021–2028 (Usd Million) 104
6.2.3 Bisulfite Conversion Kits & Reagents 104
6.2.3.1 Effective Outcomes Associated With Bisulfite Conversion To Drive Demand 104
Table 34 Epigenetics Market For Bisulfite Conversion Kits & Reagents, By Region, 2021–2028 (Usd Million) 105
Table 35 North America: Epigenetics Market For Bisulfite Conversion Kits & Reagents, By Country, 2021–2028 (Usd Million) 105
Table 36 Europe: Epigenetics Market For Bisulfite Conversion Kits & Reagents, By Country, 2021–2028 (Usd Million) 106
Table 37 Asia Pacific: Epigenetics Market For Bisulfite Conversion Kits & Reagents, By Country, 2021–2028 (Usd Million) 106
Table 38 Latin America: Epigenetics Market For Bisulfite Conversion Kits & Reagents, By Country, 2021–2028 (Usd Million) 107
6.2.4 Whole-Genome Amplification Kits & Reagents 107
6.2.4.1 Ability Of Whole-Genome Amplification To Maintain Relative Proportions Of Genes In Original Pool To Drive Adoption 107
Table 39 Epigenetics Market For Whole-Genome Amplification Kits & Reagents, By Region, 2021–2028 (Usd Million) 108
Table 40 North America: Epigenetics Market For Whole-Genome Amplification Kits & Reagents, By Country, 2021–2028 (Usd Million) 108
Table 41 Europe: Epigenetics Market For Whole-Genome Amplification Kits & Reagents, By Country, 2021–2028 (Usd Million) 109
Table 42 Asia Pacific: Epigenetics Market For Whole-Genome Amplification Kits & Reagents, By Country, 2021–2028 (Usd Million) 109
Table 43 Latin America: Epigenetics Market For Whole-Genome Amplification Kits & Reagents, By Country, 2021–2028 (Usd Million) 110
6.2.5 5-Hmc & 5-Mc Analysis Kits & Reagents 110
6.2.5.1 Introduction Of Unique Kits For 5-Mc And 5-Hmc Analysis To Support Growth 110
Table 44 Epigenetics Market For 5-Hmc & 5-Mc Analysis Kits & Reagents, By Region, 2021–2028 (Usd Million) 111
Table 45 North America: Epigenetics Market For 5-Hmc & 5-Mc Analysis Kits & Reagents, By Country, 2021–2028 (Usd Million) 111
Table 46 Europe: Epigenetics Market For 5-Hmc & 5-Mc Analysis Kits & Reagents, By Country, 2021–2028 (Usd Million) 112
Table 47 Asia Pacific: Epigenetics Market For 5-Hmc & 5-Mc Analysis Kits & Reagents, By Country, 2021–2028 (Usd Million) 112
Table 48 Latin America: Epigenetics Market For 5-Hmc & 5-Mc Analysis Kits & Reagents, By Country, 2021–2028 (Usd Million) 113
6.2.6 Histones 113
6.2.6.1 Emerging Importance Of Chromatin-Associated Proteins And Histones In Epigenetic Research To Drive Segmental Growth 113
Table 49 Epigenetics Market For Histones, By Region, 2021–2028 (Usd Million) 114
Table 50 North America: Epigenetics Market For Histones, By Country, 2021–2028 (Usd Million) 114
Table 51 Europe: Epigenetics Market For Histones, By Country, 2021–2028 (Usd Million) 115
Table 52 Asia Pacific: Epigenetics Market For Histones, By Country, 2021–2028 (Usd Million) 115
Table 53 Latin America: Epigenetics Market For Histones, By Country, 2021–2028 (Usd Million) 116
6.2.7 Other Kits & Reagents 116
Table 54 Epigenetics Market For Other Kits & Reagents, By Region, 2021–2028 (Usd Million) 117
Table 55 North America: Epigenetics Market For Other Kits & Reagents, By Country, 2021–2028 (Usd Million) 117
Table 56 Europe: Epigenetics Market For Other Kits & Reagents, By Country, 2021–2028 (Usd Million) 118
Table 57 Asia Pacific: Epigenetics Market For Other Kits & Reagents, By Country, 2021–2028 (Usd Million) 118
Table 58 Latin America: Epigenetics Market For Other Kits & Reagents, By Country, 2021–2028 (Usd Million) 119
6.3 Enzymes 119
Table 59 Epigenetics Market For Enzymes, By Type, 2021–2028 (Usd Million) 119
Table 60 Epigenetics Market For Enzymes, By Region, 2021–2028 (Usd Million) 120
Table 61 North America: Epigenetics Market For Enzymes, By Country, 2021–2028 (Usd Million) 120
Table 62 Europe: Epigenetics Market For Enzymes, By Country, 2021–2028 (Usd Million) 120
Table 63 Asia Pacific: Epigenetics Market For Enzymes, By Country, 2021–2028 (Usd Million) 121
Table 64 Latin America: Epigenetics Market For Enzymes, By Country, 2021–2028 (Usd Million) 121
6.3.1 Dna-Modifying Enzymes 121
6.3.1.1 Broadening Applications Of Dna Methylation To Favor Market Growth 121
Table 65 Epigenetics Market For Dna-Modifying Enzymes, By Region, 2021–2028 (Usd Million) 122
Table 66 North America: Epigenetics Market For Dna-Modifying Enzymes, By Country, 2021–2028 (Usd Million) 122
Table 67 Europe: Epigenetics Market For Dna-Modifying Enzymes, By Country, 2021–2028 (Usd Million) 123
Table 68 Asia Pacific: Epigenetics Market For Dna-Modifying Enzymes, By Country, 2021–2028 (Usd Million) 123
Table 69 Latin America: Epigenetics Market For Dna-Modifying Enzymes, By Country, 2021–2028 (Usd Million) 124
6.3.2 Protein-Modifying Enzymes 124
6.3.2.1 Increasing Pipeline Of Epigenetics-Based Drugs Targeting Histone-Modifying Enzymes To Drive Segmental Growth 124
Table 70 Epigenetics Market For Protein-Modifying Enzymes, By Region, 2021–2028 (Usd Million) 125
Table 71 North America: Epigenetics Market For Protein-Modifying Enzymes, By Country, 2021–2028 (Usd Million) 125
Table 72 Europe: Epigenetics Market For Protein-Modifying Enzymes, By Country, 2021–2028 (Usd Million) 126
Table 73 Asia Pacific: Epigenetics Market For Protein-Modifying Enzymes, By Country, 2021–2028 (Usd Million) 126
Table 74 Latin America: Epigenetics Market For Protein-Modifying Enzymes, By Country, 2021–2028 (Usd Million) 127
6.3.3 Other Enzymes 127
Table 75 Epigenetics Market For Other Enzymes, By Region, 2021–2028 (Usd Million) 127
Table 76 North America: Epigenetics Market For Other Enzymes, By Country, 2021–2028 (Usd Million) 128
Table 77 Europe: Epigenetics Market For Other Enzymes, By Country, 2021–2028 (Usd Million) 128
Table 78 Asia Pacific: Epigenetics Market For Other Enzymes, By Country, 2021–2028 (Usd Million) 129
Table 79 Latin America: Epigenetics Market For Other Enzymes, By Country, 2021–2028 (Usd Million) 129
6.4 Instruments & Accessories 129
6.4.1 Wide Usage Of Ngs Instruments And Sonicators To Propel Growth 129
Table 80 Epigenetics Market For Instruments & Accessories, By Region, 2021–2028 (Usd Million) 130
Table 81 North America: Epigenetics Market For Instruments & Accessories, By Country, 2021–2028 (Usd Million) 130
Table 82 Europe: Epigenetics Market For Instruments & Accessories, By Country, 2021–2028 (Usd Million) 131
Table 83 Asia Pacific: Epigenetics Market For Instruments & Accessories, By Country, 2021–2028 (Usd Million) 131
Table 84 Latin America: Epigenetics Market For Instruments & Accessories, By Country, 2021–2028 (Usd Million) 132
6.5 Software 132
6.5.1 Development Of Viable Software Solutions For Dna Methylation And Rna Analysis To Propel Growth 132
Table 85 Epigenetics Market For Software, By Region, 2021–2028 (Usd Million) 133
Table 86 North America: Epigenetics Market For Software, By Country, 2021–2028 (Usd Million) 133
Table 87 Europe: Epigenetics Market For Software, By Country, 2021–2028 (Usd Million) 134
Table 88 Asia Pacific: Epigenetics Market For Software, By Country, 2021–2028 (Usd Million) 134
Table 89 Latin America: Epigenetics Market For Software, By Country, 2021–2028 (Usd Million) 135
6.6 Services 135
6.6.1 Expanding Pool Of Service Providers To Drive Growth 135
Table 90 Epigenetics Market For Services, By Region, 2021–2028 (Usd Million) 136
Table 91 North America: Epigenetics Market For Services, By Country, 2021–2028 (Usd Million) 136
Table 92 Europe: Epigenetics Market For Services, By Country, 2021–2028 (Usd Million) 137
Table 93 Asia Pacific: Epigenetics Market For Services, By Country, 2021–2028 (Usd Million) 137
Table 94 Latin America: Epigenetics Market For Services, By Country, 2021–2028 (Usd Million) 138

7 Epigenetics Market, By Method 139
7.1 Introduction 140
Table 95 Epigenetics Market, By Method, 2021–2028 (Usd Million) 140
7.2 Dna Methylation 140
7.2.1 Increasing R&D Activities To Explore Potential Of Dna Methylation To Drive Market Growth 140
Table 96 Epigenetics Market For Dna Methylation, By Region, 2021–2028 (Usd Million) 141
Table 97 North America: Epigenetics Market For Dna Methylation, By Country, 2021–2028 (Usd Million) 141
Table 98 Europe: Epigenetics Market For Dna Methylation, By Country, 2021–2028 (Usd Million) 142
Table 99 Asia Pacific: Epigenetics Market For Dna Methylation, By Country, 2021–2028 (Usd Million) 142
Table 100 Latin America: Epigenetics Market For Dna Methylation, By Country, 2021–2028 (Usd Million) 143
7.3 Histone Modifications 143
7.3.1 Technological Advancements To Drive Segmental Growth 143
Table 101 Common Histone Modifications And Respective Locations 144
Table 102 Epigenetics Market For Histone Modifications, By Region, 2021–2028 (Usd Million) 144
Table 103 North America: Epigenetics Market For Histone Modifications, By Country, 2021–2028 (Usd Million) 145
Table 104 Europe: Epigenetics Market For Histone Modifications, By Country, 2021–2028 (Usd Million) 145
Table 105 Asia Pacific: Epigenetics Market For Histone Modifications, By Country, 2021–2028 (Usd Million) 146
Table 106 Latin America: Epigenetics Market For Histone Modifications, By Country, 2021–2028 (Usd Million) 146
7.4 Other Methods 146
Table 107 Epigenetics Market For Other Methods, By Region, 2021–2028 (Usd Million) 147
Table 108 North America: Epigenetics Market For Other Methods, By Country, 2021–2028 (Usd Million) 147
Table 109 Europe: Epigenetics Market For Other Methods, By Country, 2021–2028 (Usd Million) 148
Table 110 Asia Pacific: Epigenetics Market For Other Methods, By Country, 2021–2028 (Usd Million) 148
Table 111 Latin America: Epigenetics Market For Other Methods, By Country, 2021–2028 (Usd Million) 149

8 Epigenetics Market, By Technique 150
8.1 Introduction 151
Table 112 Epigenetics Market, By Technique, 2021–2028 (Usd Million) 151
8.2 Ngs 151
8.2.1 Ability To Offer Comprehensive Epigenetic Profiles To Propel Demand For Ngs Technique 151
Table 113 Epigenetics Market For Ngs, By Region, 2021–2028 (Usd Million) 152
Table 114 North America: Epigenetics Market For Ngs, By Country, 2021–2028 (Usd Million) 152
Table 115 Europe: Epigenetics Market For Ngs, By Country, 2021–2028 (Usd Million) 153
Table 116 Asia Pacific: Epigenetics Market For Ngs, By Country, 2021–2028 (Usd Million) 153
Table 117 Latin America: Epigenetics Market For Ngs, By Country, 2021–2028 (Usd Million) 154
8.3 Pcr & Qpcr 154
8.3.1 Rising Number Of Pcr-Based Epigenetics Service Providers To Drive Growth 154
Table 118 Epigenetics Market For Pcr & Qpcr, By Region, 2021–2028 (Usd Million) 155
Table 119 North America: Epigenetics Market For Pcr & Qpcr, By Country, 2021–2028 (Usd Million) 155
Table 120 Europe: Epigenetics Market For Pcr & Qpcr, By Country, 2021–2028 (Usd Million) 156
Table 121 Asia Pacific: Epigenetics Market For Pcr & Qpcr, By Country, 2021–2028 (Usd Million) 156
Table 122 Latin America: Epigenetics Market For Pcr & Qpcr, By Country, 2021–2028 (Usd Million) 157
8.4 Mass Spectrometry 157
8.4.1 Growing Demand For Mass Spectrometry In Comprehensive Studies On Histone Epigenetics To Boost Market 157
Table 123 Epigenetics Market For Mass Spectrometry, By Region, 2021–2028 (Usd Million) 158
Table 124 North America: Epigenetics Market For Mass Spectrometry, By Country, 2021–2028 (Usd Million) 158
Table 125 Europe: Epigenetics Market For Mass Spectrometry, By Country, 2021–2028 (Usd Million) 159
Table 126 Asia Pacific: Epigenetics Market For Mass Spectrometry, By Country, 2021–2028 (Usd Million) 159
Table 127 Latin America: Epigenetics Market For Mass Spectrometry, By Country, 2021–2028 (Usd Million) 160
8.5 Sonication 160
8.5.1 Introduction Of Improved High-Throughput Sonication Techniques To Propel Adoption 160
Table 128 Epigenetics Market For Sonication, By Region, 2021–2028 (Usd Million) 161
Table 129 North America: Epigenetics Market For Sonication, By Country, 2021–2028 (Usd Million) 161
Table 130 Europe: Epigenetics Market For Sonication, By Country, 2021–2028 (Usd Million) 162
Table 131 Asia Pacific: Epigenetics Market For Sonication, By Country, 2021–2028 (Usd Million) 162
Table 132 Latin America: Epigenetics Market For Sonication, By Country, 2021–2028 (Usd Million) 163
8.6 Other Techniques 163
Table 133 Epigenetics Market For Other Techniques, By Region, 2021–2028 (Usd Million) 164
Table 134 North America: Epigenetics Market For Other Techniques, By Country, 2021–2028 (Usd Million) 164
Table 135 Europe: Epigenetics Market For Other Techniques, By Country, 2021–2028 (Usd Million) 165
Table 136 Asia Pacific: Epigenetics Market For Other Techniques, By Country, 2021–2028 (Usd Million) 165
Table 137 Latin America: Epigenetics Market For Other Techniques, By Country, 2021–2028 (Usd Million) 166

9 Epigenetics Market, By Application 167
9.1 Introduction 168
Table 138 Epigenetics Market, By Application, 2021–2028 (Usd Million) 168
9.2 Oncology 168
9.2.1 Growing Efforts To Develop Oncology Epigenetic Drugs To Boost Market 168
Table 139 Epigenome-Targeting Cancer Drugs Approved Or In Clinical Trials 169
Table 140 Epigenetics Market For Oncology, By Region, 2021–2028 (Usd Million) 171
Table 141 North America: Epigenetics Market For Oncology, By Country, 2021–2028 (Usd Million) 171
Table 142 Europe: Epigenetics Market For Oncology, By Country, 2021–2028 (Usd Million) 172
Table 143 Asia Pacific: Epigenetics Market For Oncology, By Country, 2021–2028 (Usd Million) 172
Table 144 Latin America: Epigenetics Market For Oncology, By Country, 2021–2028 (Usd Million) 173
9.3 Metabolic Diseases 173
9.3.1 Emerging Role Of Dna Methylation In Diabetes Management To Favor Market Growth 173
Table 145 Epigenetics Market For Metabolic Diseases, By Region, 2021–2028 (Usd Million) 174
Table 146 North America: Epigenetics Market For Metabolic Diseases, By Country, 2021–2028 (Usd Million) 174
Table 147 Europe: Epigenetics Market For Metabolic Diseases, By Country, 2021–2028 (Usd Million) 175
Table 148 Asia Pacific: Epigenetics Market For Metabolic Diseases, By Country, 2021–2028 (Usd Million) 175
Table 149 Latin America: Epigenetics Market For Metabolic Diseases, By Country, 2021–2028 (Usd Million) 176
9.4 Immunology 176
9.4.1 Growing Demand For Epigenetic Products In Tumor And Transplantation Immunology To Support Growth 176
Table 150 Epigenetics Market For Immunology, By Region, 2021–2028 (Usd Million) 177
Table 151 North America: Epigenetics Market For Immunology, By Country, 2021–2028 (Usd Million) 177
Table 152 Europe: Epigenetics Market For Immunology, By Country, 2021–2028 (Usd Million) 178
Table 153 Asia Pacific: Epigenetics Market For Immunology, By Country, 2021–2028 (Usd Million) 178
Table 154 Latin America: Epigenetics Market For Immunology, By Country, 2021–2028 (Usd Million) 179
9.5 Developmental Biology 179
9.5.1 Increasing Research In Developmental Biology To Propel Growth 179
Table 155 Epigenetics Market For Developmental Biology, By Region, 2021–2028 (Usd Million) 180
Table 156 North America: Epigenetics Market For Developmental Biology, By Country, 2021–2028 (Usd Million) 180
Table 157 Europe: Epigenetics Market For Developmental Biology, By Country, 2021–2028 (Usd Million) 181
Table 158 Asia Pacific: Epigenetics Market For Developmental Biology, By Country, 2021–2028 (Usd Million) 181
Table 159 Latin America: Epigenetics Market For Developmental Biology, By Country, 2021–2028 (Usd Million) 182
9.6 Cardiovascular Diseases 182
9.6.1 Emerging Role Of Epigenetics In Understanding Etiology Of Cardiovascular Diseases To Boost Adoption 182
Table 160 Epigenetics Market For Cardiovascular Diseases, By Region, 2021–2028 (Usd Million) 183
Table 161 North America: Epigenetics Market For Cardiovascular Diseases, By Country, 2021–2028 (Usd Million) 183
Table 162 Europe: Epigenetics Market For Cardiovascular Diseases, By Country, 2021–2028 (Usd Million) 184
Table 163 Asia Pacific: Epigenetics Market For Cardiovascular Diseases, By Country, 2021–2028 (Usd Million) 184
Table 164 Latin America: Epigenetics Market For Cardiovascular Diseases, By Country, 2021–2028 (Usd Million) 185
9.7 Other Applications 185
Table 165 Epigenetics Market For Other Applications, By Region, 2021–2028 (Usd Million) 186
Table 166 North America: Epigenetics Market For Other Applications, By Country, 2021–2028 (Usd Million) 186
Table 167 Europe: Epigenetics Market For Other Applications, By Country, 2021–2028 (Usd Million) 187
Table 168 Asia Pacific: Epigenetics Market For Other Applications, By Country, 2021–2028 (Usd Million) 187
Table 169 Latin America: Epigenetics Market For Other Applications, By Country, 2021–2028 (Usd Million) 188

10 Epigenetics Market, By End User 189
10.1 Introduction 190
Table 170 Epigenetics Market, By End User, 2021–2028 (Usd Million) 190
10.2 Academic & Research Institutes 190
10.2.1 Increasing Government Investments & Collaborations To Contribute To Market Growth 190
Table 171 Epigenetics Market For Academic & Research Institutes, By Region, 2021–2028 (Usd Million) 191
Table 172 North America: Epigenetics Market For Academic & Research Institutes, By Country, 2021–2028 (Usd Million) 191
Table 173 Europe: Epigenetics Market For Academic & Research Institutes, By Country, 2021–2028 (Usd Million) 192
Table 174 Asia Pacific: Epigenetics Market For Academic & Research Institutes, By Country, 2021–2028 (Usd Million) 192
Table 175 Latin America: Epigenetics Market For Academic & Research Institutes, By Country, 2021–2028 (Usd Million) 193
10.3 Pharmaceutical & Biotechnology Companies 193
10.3.1 Growing Number Of Clinical Trials For Epigenetics-Based Drugs To Drive Growth 193
Table 176 Epigenetics Market For Pharmaceutical & Biotechnology Companies, By Region, 2021–2028 (Usd Million) 194
Table 177 North America: Epigenetics Market For Pharmaceutical & Biotechnology Companies, By Country, 2021–2028 (Usd Million) 194
Table 178 Europe: Epigenetics Market For Pharmaceutical & Biotechnology Companies, By Country, 2021–2028 (Usd Million) 195
Table 179 Asia Pacific: Epigenetics Market For Pharmaceutical & Biotechnology Companies, By Country, 2021–2028 (Usd Million) 195
Table 180 Latin America: Epigenetics Market For Pharmaceutical & Biotechnology Companies, By Country, 2021–2028 (Usd Million) 196
10.4 Hospitals & Clinics 196
10.4.1 Growing Importance Of Measurement Of Dna Methylation In Hospital Settings To Boost Market 196
Table 181 Epigenetics Market For Hospitals & Clinics, By Region, 2021–2028 (Usd Million) 197
Table 182 North America: Epigenetics Market For Hospitals & Clinics, By Country, 2021–2028 (Usd Million) 197
Table 183 Europe: Epigenetics Market For Hospitals & Clinics, By Country, 2021–2028 (Usd Million) 198
Table 184 Asia Pacific: Epigenetics Market For Hospitals & Clinics, By Country, 2021–2028 (Usd Million) 198
Table 185 Latin America: Epigenetics Market For Hospitals & Clinics, By Country, 2021–2028 (Usd Million) 199

11 Epigenetics Market, By Region 200
11.1 Introduction 201
Table 186 Epigenetics Market, By Region, 2021–2028 (Usd Million) 201
11.2 North America 201
Figure 30 North America: Epigenetics Market Snapshot 202
Table 187 North America: Epigenetics Market, By Country, 2021–2028 (Usd Million) 202
Table 188 North America: Epigenetics Market, By Product & Service, 2021–2028 (Usd Million) 203
Table 189 North America: Epigenetics Market For Kits & Reagents, By Type, 2021–2028 (Usd Million) 203
Table 190 North America: Epigenetics Market For Enzymes, By Type, 2021–2028 (Usd Million) 204
Table 191 North America: Epigenetics Market, By Method, 2021–2028 (Usd Million) 204
Table 192 North America: Epigenetics Market, By Technique, 2021–2028 (Usd Million) 204
Table 193 North America: Epigenetics Market, By Application, 2021–2028 (Usd Million) 205
Table 194 North America: Epigenetics Market, By End User, 2021–2028 (Usd Million) 205
11.2.1 Us 205
11.2.1.1 Strong Network Of Well-Established Epigenetic Product Manufacturers To Drive Market Growth 205
Table 195 Us: Epigenetics Market, By Product & Service, 2021–2028 (Usd Million) 206
Table 196 Us: Epigenetics Market For Kits & Reagents, By Type, 2021–2028 (Usd Million) 207
Table 197 Us: Epigenetics Market For Enzymes, By Type, 2021–2028 (Usd Million) 207
Table 198 Us: Epigenetics Market, By Method, 2021–2028 (Usd Million) 208
Table 199 Us: Epigenetics Market, By Technique, 2021–2028 (Usd Million) 208
Table 200 Us: Epigenetics Market, By Application, 2021–2028 (Usd Million) 209
Table 201 Us: Epigenetics Market, By End User, 2021–2028 (Usd Million) 209
11.2.2 Canada 209
11.2.2.1 Increasing Government Initiatives To Boost Epigenetics Research 209
Table 202 Canada: Epigenetics Market, By Product & Service, 2021–2028 (Usd Million) 210
Table 203 Canada: Epigenetics Market For Kits & Reagents, By Type, 2021–2028 (Usd Million) 211
Table 204 Canada: Epigenetics Market For Enzymes, By Type, 2021–2028 (Usd Million) 211
Table 205 Canada: Epigenetics Market, By Method, 2021–2028 (Usd Million) 212
Table 206 Canada: Epigenetics Market, By Technique, 2021–2028 (Usd Million) 212
Table 207 Canada: Epigenetics Market, By Application, 2021–2028 (Usd Million) 213
Table 208 Canada: Epigenetics Market, By End User, 2021–2028 (Usd Million) 213
11.3 North America: Recession Impact 213
11.4 Europe 214
Table 209 Europe: Epigenetics Market, By Country, 2021–2028 (Usd Million) 214
Table 210 Europe: Epigenetics Market, By Product & Service, 2021–2028 (Usd Million) 215
Table 211 Europe: Epigenetics Market For Kits & Reagents, By Type, 2021–2028 (Usd Million) 215
Table 212 Europe: Epigenetics Market For Enzymes, By Type, 2021–2028 (Usd Million) 216
Table 213 Europe: Epigenetics Market, By Method, 2021–2028 (Usd Million) 216
Table 214 Europe: Epigenetics Market, By Technique, 2021–2028 (Usd Million) 216
Table 215 Europe: Epigenetics Market, By Application, 2021–2028 (Usd Million) 217
Table 216 Europe: Epigenetics Market, By End User, 2021–2028 (Usd Million) 217
11.4.1 Germany 217
11.4.1.1 Significant Investments In Ngs To Boost Adoption Of Epigenetics Products 217
Table 217 Germany: Epigenetics Market, By Product & Service, 2021–2028 (Usd Million) 218
Table 218 Germany: Epigenetics Market For Kits & Reagents, By Type, 2021–2028 (Usd Million) 219
Table 219 Germany: Epigenetics Market For Enzymes, By Type, 2021–2028 (Usd Million) 219
Table 220 Germany: Epigenetics Market, By Method, 2021–2028 (Usd Million) 220
Table 221 Germany: Epigenetics Market, By Technique, 2021–2028 (Usd Million) 220
Table 222 Germany: Epigenetics Market, By Application, 2021–2028 (Usd Million) 220
Table 223 Germany: Epigenetics Market, By End User, 2021–2028 (Usd Million) 221
11.4.2 Uk 221
11.4.2.1 Rising Acceptance Of Genome-Based Diagnostic Techniques By Clinicians To Support Growth 221
Table 224 Uk: Epigenetics Market, By Product & Service, 2021–2028 (Usd Million) 222
Table 225 Uk: Epigenetics Market For Kits & Reagents, By Type, 2021–2028 (Usd Million) 222
Table 226 Uk: Epigenetics Market For Enzymes, By Type, 2021–2028 (Usd Million) 223
Table 227 Uk: Epigenetics Market, By Method, 2021–2028 (Usd Million) 223
Table 228 Uk: Epigenetics Market, By Technique, 2021–2028 (Usd Million) 223
Table 229 Uk: Epigenetics Market, By Application, 2021–2028 (Usd Million) 224
Table 230 Uk: Epigenetics Market, By End User, 2021–2028 (Usd Million) 224
11.4.3 France 224
11.4.3.1 Growing Demand For Pcr Technologies To Propel Market Growth 224
Table 231 France: Epigenetics Market, By Product & Service, 2021–2028 (Usd Million) 225
Table 232 France: Epigenetics Market For Kits & Reagents, By Type, 2021–2028 (Usd Million) 225
Table 233 France: Epigenetics Market For Enzymes, By Type, 2021–2028 (Usd Million) 226
Table 234 France: Epigenetics Market, By Method, 2021–2028 (Usd Million) 226
Table 235 France: Epigenetics Market, By Technique, 2021–2028 (Usd Million) 226
Table 236 France: Epigenetics Market, By Application, 2021–2028 (Usd Million) 227
Table 237 France: Epigenetics Market, By End User, 2021–2028 (Usd Million) 227
11.4.4 Italy 227
11.4.4.1 High Incidence Of Cancer To Support Market Growth 227
Table 238 Italy: Epigenetics Market, By Product & Service, 2021–2028 (Usd Million) 228
Table 239 Italy: Epigenetics Market For Kits & Reagents, By Type, 2021–2028 (Usd Million) 228
Table 240 Italy: Epigenetics Market For Enzymes, By Type, 2021–2028 (Usd Million) 229
Table 241 Italy: Epigenetics Market, By Method, 2021–2028 (Usd Million) 229
Table 242 Italy: Epigenetics Market, By Technique, 2021–2028 (Usd Million) 229
Table 243 Italy: Epigenetics Market, By Application, 2021–2028 (Usd Million) 230
Table 244 Italy: Epigenetics Market, By End User, 2021–2028 (Usd Million) 230
11.4.5 Spain 230
11.4.5.1 Well-Established Network Of Research Centers And Universities To Boost Market 230
Table 245 Spain: Epigenetics Market, By Product & Service, 2021–2028 (Usd Million) 231
Table 246 Spain: Epigenetics Market For Kits & Reagents, By Type, 2021–2028 (Usd Million) 231
Table 247 Spain: Epigenetics Market For Enzymes, By Type, 2021–2028 (Usd Million) 232
Table 248 Spain: Epigenetics Market, By Method, 2021–2028 (Usd Million) 232
Table 249 Spain: Epigenetics Market, By Technique, 2021–2028 (Usd Million) 232
Table 250 Spain: Epigenetics Market, By Application, 2021–2028 (Usd Million) 233
Table 251 Spain: Epigenetics Market, By End User, 2021–2028 (Usd Million) 233
11.4.6 Rest Of Europe 233
Table 252 Rest Of Europe: Epigenetics Market, By Product & Service, 2021–2028 (Usd Million) 234
Table 253 Rest Of Europe: Epigenetics Market For Kits & Reagents, By Type, 2021–2028 (Usd Million) 234
Table 254 Rest Of Europe: Epigenetics Market For Enzymes, By Type, 2021–2028 (Usd Million) 235
Table 255 Rest Of Europe: Epigenetics Market, By Method, 2021–2028 (Usd Million) 235
Table 256 Rest Of Europe: Epigenetics Market, By Technique, 2021–2028 (Usd Million) 235
Table 257 Rest Of Europe: Epigenetics Market, By Application, 2021–2028 (Usd Million) 236
Table 258 Rest Of Europe: Epigenetics Market, By End User, 2021–2028 (Usd Million) 236
11.5 Europe: Recession Impact 236
11.6 Asia Pacific 237
Figure 31 Asia Pacific: Epigenetics Market Snapshot 238
Table 259 Asia Pacific: Epigenetics Market, By Country, 2021–2028 (Usd Million) 239
Table 260 Asia Pacific: Epigenetics Market, By Product & Service, 2021–2028 (Usd Million) 239
Table 261 Asia Pacific: Epigenetics Market For Kits & Reagents, By Type, 2021–2028 (Usd Million) 240
Table 262 Asia Pacific: Epigenetics Market For Enzymes, By Type, 2021–2028 (Usd Million) 240
Table 263 Asia Pacific: Epigenetics Market, By Method, 2021–2028 (Usd Million) 241
Table 264 Asia Pacific: Epigenetics Market, By Technique, 2021–2028 (Usd Million) 241
Table 265 Asia Pacific: Epigenetics Market, By Application, 2021–2028 (Usd Million) 242
Table 266 Asia Pacific: Epigenetics Market, By End User, 2021–2028 (Usd Million) 242
11.6.1 Japan 242
11.6.1.1 Increasing Collaborations Between Research & Academic Organizations To Favor Market Growth 242
Table 267 Japan: Epigenetics Market, By Product & Service, 2021–2028 (Usd Million) 243
Table 268 Japan: Epigenetics Market For Kits & Reagents, By Type, 2021–2028 (Usd Million) 244
Table 269 Japan: Epigenetics Market For Enzymes, By Type, 2021–2028 (Usd Million) 244
Table 270 Japan: Epigenetics Market, By Method, 2021–2028 (Usd Million) 245
Table 271 Japan: Epigenetics Market, By Technique, 2021–2028 (Usd Million) 245
Table 272 Japan: Epigenetics Market, By Application, 2021–2028 (Usd Million) 246
Table 273 Japan: Epigenetics Market, By End User, 2021–2028 (Usd Million) 246
11.6.2 China 246
11.6.2.1 High Demand For Personalized Medicine To Fuel Growth 246
Table 274 China: Epigenetics Market, By Product & Service, 2021–2028 (Usd Million) 247
Table 275 China: Epigenetics Market For Kits & Reagents, By Type, 2021–2028 (Usd Million) 248
Table 276 China: Epigenetics Market For Enzymes, By Type, 2021–2028 (Usd Million) 248
Table 277 China: Epigenetics Market, By Method, 2021–2028 (Usd Million) 249
Table 278 China: Epigenetics Market, By Technique, 2021–2028 (Usd Million) 249
Table 279 China: Epigenetics Market, By Application, 2021–2028 (Usd Million) 250
Table 280 China: Epigenetics Market, By End User, 2021–2028 (Usd Million) 250
11.6.3 India 250
11.6.3.1 Expanding Base Of Biotechnology Facilities To Drive Growth 250
Table 281 India: Epigenetics Market, By Product & Service, 2021–2028 (Usd Million) 251
Table 282 India: Epigenetics Market For Kits & Reagents, By Type, 2021–2028 (Usd Million) 252
Table 283 India: Epigenetics Market For Enzymes, By Type, 2021–2028 (Usd Million) 252
Table 284 India: Epigenetics Market, By Method, 2021–2028 (Usd Million) 253
Table 285 India: Epigenetics Market, By Technique, 2021–2028 (Usd Million) 253
Table 286 India: Epigenetics Market, By Application, 2021–2028 (Usd Million) 254
Table 287 India: Epigenetics Market, By End User, 2021–2028 (Usd Million) 254
11.6.4 South Korea 254
11.6.4.1 Increasing Demand For Epigenetic Testing To Boost Growth 254
Table 288 South Korea: Epigenetics Market, By Product & Service, 2021–2028 (Usd Million) 255
Table 289 South Korea: Epigenetics Market For Kits & Reagents, By Type, 2021–2028 (Usd Million) 255
Table 290 South Korea: Epigenetics Market For Enzymes, By Type, 2021–2028 (Usd Million) 256
Table 291 South Korea: Epigenetics Market, By Method, 2021–2028 (Usd Million) 256
Table 292 South Korea: Epigenetics Market, By Technique, 2021–2028 (Usd Million) 256
Table 293 South Korea: Epigenetics Market, By Application, 2021–2028 (Usd Million) 257
Table 294 South Korea: Epigenetics Market, By End User, 2021–2028 (Usd Million) 257
11.6.5 Rest Of Asia Pacific 257
Table 295 Rest Of Asia Pacific: Epigenetics Market, By Product & Service, 2021–2028 (Usd Million) 258
Table 296 Rest Of Asia Pacific: Epigenetics Market For Kits & Reagents, By Type, 2021–2028 (Usd Million) 258
Table 297 Rest Of Asia Pacific: Epigenetics Market For Enzymes, By Type, 2021–2028 (Usd Million) 259
Table 298 Rest Of Asia Pacific: Epigenetics Market, By Method, 2021–2028 (Usd Million) 259
Table 299 Rest Of Asia Pacific: Epigenetics Market, By Technique, 2021–2028 (Usd Million) 259
Table 300 Rest Of Asia Pacific: Epigenetics Market, By Application, 2021–2028 (Usd Million) 260
Table 301 Rest Of Asia Pacific: Epigenetics Market, By End User, 2021–2028 (Usd Million) 260
11.6.6 Asia Pacific: Recession Impact 260
11.7 Latin America 261
Table 302 Latin America: Epigenetics Market, By Country, 2021–2028 (Usd Million) 261
Table 303 Latin America: Epigenetics Market, By Product & Service, 2021–2028 (Usd Million) 262
Table 304 Latin America: Epigenetics Market For Kits & Reagents, By Type, 2021–2028 (Usd Million) 262
Table 305 Latin America: Epigenetics Market For Enzymes, By Type, 2021–2028 (Usd Million) 263
Table 306 Latin America: Epigenetics Market, By Method, 2021–2028 (Usd Million) 263
Table 307 Latin America: Epigenetics Market, By Technique, 2021–2028 (Usd Million) 263
Table 308 Latin America: Epigenetics Market, By Application, 2021–2028 (Usd Million) 264
Table 309 Latin America: Epigenetics Market, By End User, 2021–2028 (Usd Million) 264
11.7.1 Brazil 264
11.7.1.1 Increasing Number Of Healthcare Providers Incorporating Epigenetic Testing To Boost Growth 264
Table 310 Brazil: Epigenetics Market, By Product & Service, 2021–2028 (Usd Million) 265
Table 311 Brazil: Epigenetics Market For Kits & Reagents, By Type, 2021–2028 (Usd Million) 265
Table 312 Brazil: Epigenetics Market For Enzymes, By Type, 2021–2028 (Usd Million) 266
Table 313 Brazil: Epigenetics Market, By Method, 2021–2028 (Usd Million) 266
Table 314 Brazil: Epigenetics Market, By Technique, 2021–2028 (Usd Million) 266
Table 315 Brazil: Epigenetics Market, By Application, 2021–2028 (Usd Million) 267
Table 316 Brazil: Epigenetics Market, By End User, 2021–2028 (Usd Million) 267
11.7.2 Mexico 267
11.7.2.1 Growing Adoption Of Cutting-Edge Technologies To Support Growth 267
Table 317 Mexico: Epigenetics Market, By Product & Service, 2021–2028 (Usd Million) 268
Table 318 Mexico: Epigenetics Market For Kits & Reagents, By Type, 2021–2028 (Usd Million) 268
Table 319 Mexico: Epigenetics Market For Enzymes, By Type, 2021–2028 (Usd Million) 269
Table 320 Mexico: Epigenetics Market, By Method, 2021–2028 (Usd Million) 269
Table 321 Mexico: Epigenetics Market, By Technique, 2021–2028 (Usd Million) 269
Table 322 Mexico: Epigenetics Market, By Application, 2021–2028 (Usd Million) 270
Table 323 Mexico: Epigenetics Market, By End User, 2021–2028 (Usd Million) 270
11.7.3 Rest Of Latin America 270
Table 324 Rest Of Latin America: Epigenetics Market, By Product & Service, 2021–2028 (Usd Million) 271
Table 325 Rest Of Latin America: Epigenetics Market For Kits & Reagents, By Type, 2021–2028 (Usd Million) 271
Table 326 Rest Of Latin America: Epigenetics Market For Enzymes, By Type, 2021–2028 (Usd Million) 272
Table 327 Rest Of Latin America: Epigenetics Market, By Method, 2021–2028 (Usd Million) 272
Table 328 Rest Of Latin America: Epigenetics Market, By Technique, 2021–2028 (Usd Million) 272
Table 329 Rest Of Latin America: Epigenetics Market, By Application, 2021–2028 (Usd Million) 273
Table 330 Rest Of Latin America: Epigenetics Market, By End User, 2021–2028 (Usd Million) 273
11.7.4 Latin America: Recession Impact 273
11.8 Middle East 274
11.8.1 Increase In Funding And Partnerships In Research Sector To Boost Growth 274
Table 331 Middle East: Epigenetics Market, By Product & Service, 2021–2028 (Usd Million) 274
Table 332 Middle East: Epigenetics Market For Kits & Reagents, By Type, 2021–2028 (Usd Million) 275
Table 333 Middle East: Epigenetics Market For Enzymes, By Type, 2021–2028 (Usd Million) 275
Table 334 Middle East: Epigenetics Market, By Method, 2021–2028 (Usd Million) 276
Table 335 Middle East: Epigenetics Market, By Technique, 2021–2028 (Usd Million) 276
Table 336 Middle East: Epigenetics Market, By Application, 2021–2028 (Usd Million) 277
Table 337 Middle East: Epigenetics Market, By End User, 2021–2028 (Usd Million) 277
11.8.2 Middle East: Recession Impact 277
11.9 Africa 278
11.9.1 Growing Collaborations To Support Growth In Coming Years 278
Table 338 Africa: Epigenetics Market, By Product & Service, 2021–2028 (Usd Million) 278
Table 339 Africa: Epigenetics Market For Kits & Reagents, By Type, 2021–2028 (Usd Million) 279
Table 340 Africa: Epigenetics Market For Enzymes, By Type, 2021–2028 (Usd Million) 279
Table 341 Africa: Epigenetics Market, By Method, 2021–2028 (Usd Million) 280
Table 342 Africa: Epigenetics Market, By Technique, 2021–2028 (Usd Million) 280
Table 343 Africa: Epigenetics Market, By Application, 2021–2028 (Usd Million) 281
Table 344 Africa: Epigenetics Market, By End User, 2021–2028 (Usd Million) 281
11.9.2 Africa: Recession Impact 281

12 Competitive Landscape 282
12.1 Introduction 282
12.2 Strategies Adopted By Key Players 283
Figure 32 Epigenetics Market: Strategies Adopted By Key Players 283
12.3 Revenue Analysis 284
Figure 33 Revenue Analysis Of Key Players, 2020–2022 284
12.4 Market Share Analysis 284
Figure 34 Epigenetics Market: Market Share Analysis Of Key Players (2022) 285
Table 345 Epigenetics Market: Degree Of Competition 285
12.5 Company Evaluation Matrix 286
12.5.1 Stars 286
12.5.2 Emerging Leaders 287
12.5.3 Pervasive Players 287
12.5.4 Participants 287
Figure 35 Epigenetics Market: Company Evaluation Matrix, 2022 288
12.5.5 Company Footprint Analysis 289
Table 346 Epigenetics Market: Product Footprint Analysis 289
Table 347 Epigenetics Market: Regional Footprint Analysis 290
12.6 Start-Up/Sme Evaluation Quadrant 291
12.6.1 Progressive Companies 291
12.6.2 Responsive Companies 291
12.6.3 Dynamic Companies 291
12.6.4 Starting Blocks 291
Figure 36 Epigenetics Market: Start-Up/Sme Evaluation Matrix, 2022 292
12.6.5 Competitive Benchmarking Of Start-Up/Sme Players 293
Table 348 Epigenetics Market: Details Of Start-Up/Sme Players 293
Table 349 Epigenetics Market: Competitive Benchmarking Of Start-Ups/Sme Players 294
12.7 Competitive Scenario & Trends 294
12.7.1 Product Launches & Approvals 294
Table 350 Epigenetics Market: Product Launches & Approvals, January 2021–September 2023 294
12.7.2 Deals 295
Table 351 Epigenetics Market: Deals, January 2021–September 2023 295
12.7.3 Other Developments 296
Table 352 Epigenetics Market: Other Developments, January 2021–September 2023 296

13 Company Profiles 297
(Business Overview, Products Offered, Recent Developments, Mnm View)*
13.1 Key Market Players 297
13.1.1 Thermo Fisher Scientific Inc. 297
Table 353 Thermo Fisher Scientific Inc.: Business Overview 297
Figure 37 Thermo Fisher Scientific Inc.: Company Snapshot (2022) 298
13.1.2 Illumina, Inc. 301
Table 354 Illumina, Inc.: Business Overview 301
Figure 38 Illumina, Inc.: Company Snapshot (2022) 302
13.1.3 Merck Kgaa 305
Table 355 Merck Kgaa: Business Overview 305
Figure 39 Merck Kgaa: Company Snapshot (2022) 306
13.1.4 Pacbio 309
Table 356 Pacbio: Business Overview 309
Figure 40 Pacbio: Company Snapshot (2022) 310
13.1.5 Abcam Plc 313
Table 357 Abcam Plc: Business Overview 313
Figure 41 Abcam Plc: Company Snapshot (2022) 314
13.1.6 Bio-Rad Laboratories, Inc. 317
Table 358 Bio-Rad Laboratories, Inc.: Business Overview 317
Figure 42 Bio-Rad Laboratories, Inc.: Company Snapshot (2022) 318
13.1.7 Active Motif Inc. 322
Table 359 Active Motif Inc.: Business Overview 322
13.1.8 New England Biolabs 326
Table 360 New England Biolabs: Business Overview 326
13.1.9 Qiagen 329
Table 361 Qiagen: Business Overview 329
Figure 43 Qiagen: Company Snapshot (2022) 330
13.1.10 Zymo Research Corporation 332
Table 362 Zymo Research Corporation: Business Overview 332
13.1.11 Revvity 335
Table 363 Revvity: Business Overview 335
Figure 44 Revvity: Company Snapshot (2022) 336
13.1.12 Diagenode Sa (A Hologic Company) 338
Table 364 Diagenode Sa (A Hologic Company): Business Overview 338
13.1.13 F. Hoffmann-La Roche Ltd. 341
Table 365 F. Hoffmann-La Roche Ltd.: Business Overview 341
Figure 45 F. Hoffmann-La Roche Ltd.: Company Snapshot (2022) 342
13.1.14 Promega Corporation 343
Table 366 Promega Corporation: Business Overview 343
13.1.15 Epigentek Group Inc. 345
Table 367 Epigentek Group Inc.: Business Overview 345
13.2 Other Players 349
13.2.1 Epicypher 349
13.2.2 Fios Genomics 350
13.2.3 Genomescan 351
13.2.4 Creative Biogene 352
13.2.5 Bps Bioscience, Inc. 353
13.2.6 Abnova Corporation 354
13.2.7 Creative Diagnostics 355
13.2.8 Biomodal (Formerly Cambridge Epigenetix) 356
13.2.9 Integrated Dna Technologies, Inc. 356
13.2.10 Novogene Co., Ltd. 358
*Details On Business Overview, Products Offered, Recent Developments, Mnm View Might Not Be Captured In Case Of Unlisted Companies.

14 Appendix 359
14.1 Discussion Guide 359
14.2 Knowledgestore: Marketsandmarkets’ Subscription Portal 363
14.3 Customization Options 365
14.4 Related Reports 365
14.5 Author Details 366

  • Global Cytokine Inhibitor Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Cytokine Inhibitor market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The development prospects of cytokine inhibitors are very broad, and these drugs have many medical applications and researches. Cytokine inhibitors can reduce The activity of cytokines, thereby inhibiting their role in immune responses and reducing The activation of immune cells and The occurrence o......
  • Global Microbial Growth Media Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    Microbial Growth Media is a nutrient component required by microorganisms, containing a variety of trace elements and trace elements, such as copper, iron, zinc, cobalt, manganese, etc. The global Microbial Growth Media market was valued at US$ 8007 million in 2023 and is anticipated to reach US$ 11530 million by 2030, witnessing a CAGR of 5.3% during The forecast period 2024-2030. The market for microbial growth media is essential in microbiology and biotechnology rese......
  • Global Protein Biochip Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 92
    Protein Biochip is a small Protein array used to quickly detect a large number of unknown proteins. It works in a similar way to a DNA chip. First, a large number of known proteins (such as monoclonal antibodies) are placed on a small substrate and then exposed to and reacted with The unknown protein sample. Due to The specific binding between The antigen and The antibody, it can finally be detected by means of laser. The global Protein Biochip market was valued at US$ 145 million i......
  • Global Isothermal Nucleic Acid Amplification Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 103
    Isothermal nucleic acid amplification is referred to isothermal nucleic acid amplification technology. And in this report, we get The statistics on reagents used in isothermal nucleic acid amplification technology. Nucleic acid isothermal amplification is a newer technique that amplifies DNA or RNA specific fragment from few copies to billion-fold copies under a one temperature condition, unlike PCR amplification that needs at least 30-35 thermal cycles to accomplish The reaction. T......
  • Global Microfluidics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Microfluidics market size was valued at US$ 3118.7 million in 2023. With growing demand in downstream market, the Microfluidics is forecast to a readjusted size of US$ 7707.1 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Microfluidics market. Microfluidics are expected to show stable growth in the future market. However, product differentiation, re......
  • Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 122
    According to our LPI (LP Information) latest study, the global Isothermal Nucleic Acid Amplification Technology (INAAT) market size was valued at US$ 6141.3 million in 2023. With growing demand in downstream market, the Isothermal Nucleic Acid Amplification Technology (INAAT) is forecast to a readjusted size of US$ 11250 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Isothermal Nucleic Acid Amplification Technol......
  • Global Cytokines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 119
    According to our LPI (LP Information) latest study, the global Cytokines market size was valued at US$ 203730 million in 2023. With growing demand in downstream market, the Cytokines is forecast to a readjusted size of US$ 611910 million by 2030 with a CAGR of 17.0% during review period. The research report highlights the growth potential of the global Cytokines market. Cytokines are expected to show stable growth in the future market. However, product differentiation, reducing costs, an......
  • Global Western Blot Imagers Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Western Blot Imagers market size was valued at US$ 406 million in 2023. With growing demand in downstream market, the Western Blot Imagers is forecast to a readjusted size of US$ 578.4 million by 2030 with a CAGR of 5.2% during review period. The research report highlights the growth potential of the global Western Blot Imagers market. Western Blot Imagers are expected to show stable growth in the future market. However, prod......
  • Global Procalcitonin Antibody Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 125
    According to our LPI (LP Information) latest study, the global Procalcitonin Antibody market size was valued at US$ million in 2023. With growing demand in downstream market, the Procalcitonin Antibody is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Procalcitonin Antibody market. Procalcitonin Antibody are expected to show stable growth in the future market. However, product di......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs